Substance / Medication

Dust

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

No related conditions have been mapped yet. Condition-intervention linkages are derived from SNOMED CT relationships and will expand as the knowledge graph grows.

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Short-term exposure to desert dust and sandstorms and all-cause and cause-specific mortality and morbidity: A systematic review and meta-analysis.
Tobías Aurelio, Querol Xavier, Roqué Marta et al. · Environ Int · 2025
PMID: 39889591Meta-Analysis
Are There Effective Methods to Reduce Exposure to House Dust Mite Allergens? A Meta-Analysis of Randomized Clinical Trials.
Sobczak Marharyta, Kowal Krzysztof, Pawliczak Rafał · Int Forum Allergy Rhinol · 2025
PMID: 40089899Meta-Analysis
Individual differences in response to dust-mite-allergen specific immunotherapy in allergic rhinitis: a meta-analysis of randomized controlled trials.
Fang Dandan, Wang Jiajia, Li Jingyun et al. · Expert Rev Clin Immunol · 2025
PMID: 40285880Meta-Analysis
Stone dust in endourology: a systematic review of its definition, management, and clinical impact.
Moretto Stefano, Quarà Alberto, Zorzi Federico et al. · BJU Int · 2025
PMID: 40345994Meta-AnalysisFull text (PMC)
Association between occupational and environmental dust exposure and autoimmune diseases: A systematic review and meta-analysis.
Lee Seunghyun, Jo Ah-Reum, Kim Youjin et al. · J Autoimmun · 2025
PMID: 40418862Meta-Analysis
Designing a Mitigation Plan for Health Facilities in Dust Hazard: A Sequential Exploratory Mixed-Methods Study.
Sarani Arezoo, Tavan Asghar, Bahaadinbeigy Kambiz et al. · Disaster Med Public Health Prep · 2025
PMID: 41158049Meta-Analysis
Wood dust exposure and small cell lung cancer: a systematic review and meta-analysis.
Curiel-García Teresa, Candal-Pedreira Cristina, Varela-Lema Leonor et al. · J Expo Sci Environ Epidemiol · 2024
PMID: 37012384Meta-Analysis
Ambient dust pollution with all-cause, cardiovascular and respiratory mortality: A systematic review and meta-analysis.
Pouri Nasrin, Karimi Behrooz, Kolivand Ali et al. · Sci Total Environ · 2024
PMID: 38042201Meta-Analysis
A systematic review of global distribution, sources and exposure risk of phthalate esters (PAEs) in indoor dust.
Li Junjie, Liu Baolin, Yu Yong et al. · J Hazard Mater · 2024
PMID: 38678719Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dust (substance)
SNOMED CT
33008008
UMLS CUI
C0013330

Clinical Data

This intervention maps to 0 entities in the Ltrl knowledge graph.

0
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.